Coffee tends to arrive fast and leave faster: a sharp 45 minutes, then the drop. Many matcha drinkers describe something different, a slower, steadier climb that holds for hours without the jittery edge. The caffeine molecule is identical in both cups. What separates them appears to be a single amino acid, L-theanine, found almost only in the tea plant. Here is what the research suggests, framed honestly, including the parts science hasn't settled.
A note before we start. None of what follows is an FDA-approved health claim. Read it as what studies indicate, not as medical promise.
The caffeine, by the numbers
Matcha is not a gentle drink because it's low in caffeine. By the primary academic review (PMC7796401), matcha runs 18.9 to 44.4 mg of caffeine per gram, above regular green tea (11.3 to 24.67 mg/g) and well above coffee beans by weight (10 to 12 mg/g).
Per serving the picture evens out. A 2-gram bowl carries roughly 38 to 89 mg of caffeine; a coffee lands somewhere around 95 to 200 mg depending on how it's made. One quirk worth knowing: higher-grade matcha often carries more caffeine, because longer shading builds up caffeine and theanine together.
What L-theanine is, and where it comes from
L-theanine is the umami compound, and its presence traces straight back to the shade. When tencha plants are covered for weeks before harvest, the light-starved leaf slows its conversion of amino acids into catechins, so theanine pools instead of being spent. More shade means more L-theanine, which means more umami and, the research suggests, more of the calming effect.
The amounts vary widely by grade. The PMC review (PMC7796401) reports up to 44.65 mg/g in matcha powder (dry weight), while a separate measurement in brewed infusions found 6.1 mg/L — a different unit that cannot be compared directly to powder values. Mecene Market reports a general range of 20 to 40 mg per gram across matcha grades. Later-flush second-harvest powder carries meaningfully less than first-harvest ceremonial leaf. This is why grade isn't only a flavour question; the compound people drink matcha for is concentrated in the better leaf.
How the two may work together
The proposed mechanism is reasonably well studied at the bench, even if human outcomes still need more trials. L-theanine appears to enhance signalling through GABA receptors, the brain's calming, inhibitory system, the same broad target as some anti-anxiety drugs. It also seems to act as a mild antagonist at glutamate receptors, putting a brake on the very excitatory signals caffeine amplifies. Worth keeping honest: most of this mechanistic detail comes from cell and animal studies, not from imaging the brains of people sipping matcha.
Put plainly: caffeine pushes the accelerator, L-theanine eases the brake. The combination is often described as "calm alertness," focus without the jitters.
What the studies support
Here the evidence is genuinely encouraging, with the usual caveats. A 2025 systematic review and meta-analysis in Nutrition Reviews pooled randomized trials and concluded that L-theanine plus caffeine, versus placebo, "likely improves performance in attentional tasks" and favours alertness, though the authors are careful to flag wide confidence intervals and real uncertainty about size and direction. That is the isolated-compounds story. For whole matcha specifically, a 2021 placebo-controlled trial (Baba et al., Nutrients) had middle-aged and older adults take daily matcha, caffeine, or placebo: caffeine alone mostly sped reaction times, but matcha — caffeine plus theanine plus catechins together — increased the amount of work completed under a stress-inducing task, leading the authors to conclude matcha "improves both attention and work performance" beyond caffeine alone.
The often-cited "4 to 6 hours of energy" is best treated with caution. Many matcha drinkers report sustained energy lasting three to five hours, but individual responses vary and this timing comes from consumer accounts, not a controlled study.
What the research does NOT yet prove
This is where the honest line sits, and most matcha writing crosses it.
EGCG, the most abundant catechin in matcha, is real and well measured. But the cancer claims you may have seen rest on in-vitro and animal models only. Do not read them as evidence that matcha prevents cancer. The PMC review's own authors are blunt: "the direct impact and mechanisms responsible for the properties of matcha tea have not been sufficiently explored," and they call for randomized clinical trials.
So: matcha may support calm focus, the mechanism is plausible and partly trial-backed, and the antioxidant story is promising but unproven in humans. Anyone telling you matcha treats or cures anything has left the evidence behind.
(One pleasant aside the review notes: matcha powder carries 1.63 to 3.98 mg of vitamin C per gram, more than double other green teas. A nice extra, not a headline.)
Practical guidance
- Matcha still contains real caffeine. It isn't suited to caffeine-sensitive people, those who are pregnant, or anyone with an anxiety disorder without first talking to a clinician.
- The L-theanine benefit is most pronounced in high-grade, shade-grown matcha. Culinary grade carries far less per gram (Mecene Market).
- For focus, many drinkers take matcha about 30 minutes before demanding work, and avoid it within four to six hours of sleep.
Why the good leaf holds more of all this comes down to shade and grade, which is the subject of grades, explained and the regions guide. When you're ready to buy, the matcha buying guide explains how to read labels, spot fakes, and choose the right grade for focus use.
Key facts
- Matcha: 18.9–44.4 mg caffeine/g (PMC7796401), higher by weight than green tea or coffee; ~38–89 mg per 2 g serving.
- L-theanine in matcha powder reaches up to ~44.65 mg/g dry weight (PMC7796401); Mecene Market reports a general range of 20–40 mg/g across grades; shade-growing drives concentration in higher-grade leaf.
- A 2025 Nutrition Reviews meta-analysis found caffeine + L-theanine likely improves attention-task performance and alertness vs placebo (with notable uncertainty); a 2021 Nutrients RCT (Baba et al.) found whole matcha beat caffeine alone for work output under stress.
- EGCG anticancer findings are in-vitro/animal only; the PMC authors call for clinical trials. No health claims are FDA-approved.